Identifying the Best Treatments

for Patients with Rare Cancers

Rare cancers present special challenges for patients and their physicians.  Owing to a dearth of clinical trials in most rare cancer types, chemotherapy options often are few.

Add to that the fact that most oncologists encounter rare cancers only infrequently and the task of choosing an effective treatment becomes even more uncertain.

Here is where the use of Precision Functional Cancer Profiling becomes especially useful.  Instead of accepting unproven treatments and/or blindly entering an investigational clinical trial, patients can use Precision Functional Cancer Profiling to pinpoint the most highly promising, personalized chemotherapy treatment for specifically for themselves.  

Precision Functional Cancer Profiling shows objectively how a wide range of drugs in all classes - standard cytotoxic, immunologic, kinase targeted, and anti-angiogenic - work against each patient’s own, living cancer cells.

Armed with this crucial information it then becomes possible to design the most highly proming treatment regimen for each patient without resorting to guesswork.

Alternatively, patients who are determined to enter a clinical trial can use the information to select one that involves the use of drugs shown objectively to work effecively against their own cancer cells.

Precision Functional Cancer Profiling takes the guesswork out of choosing effective treatments for patients with rare cancer types.